v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

EVALUATING THE SIGNIFICANCE OF LIVER PRETREATMENT BIOPSY AND BASIC DIAGNOSIS OF MENTAL HEALTH DISORDERS ON HEPATITIS C TREATMENT

AUTHORS:

Dr Muhammad Farooq, Dr Muhammad Junaid Khan, Dr Waqas Khan, Dr Muhammad Ilyas, Dr Zia ur Rahman

ABSTRACT:

Aim: This survey was conducted to characterize overall treatment response and completion rates among the hepatitis C patient population in a metropolitan VA medical center. In addition, we investigated whether pre-treatment liver biopsy is a positive indicator of treatment completion and whether the presence of psychological well-being problems is a negative indicator of treatment completion. Methods: The examination chart survey was conducted on the 375 patients who were treated for HCV and met the survey consideration limits between March 2019 to February 2020 at our foundation. Our current research was conducted at Sir Ganga Ram Hospital, Lahore from March 2019 to February 2020. Clinical information was obtained from the mechanized framework of patient records and was broken down for specific limitations. Results. A continuous virologic reaction was observed in 116 (31%) patients. 169 (45%) patients completed a full course of treatment. In addition, 44% of patients who underwent liver biopsy prior to treatment completed treatment compared to 46% of patients who did not undergo liver biopsy prior to treatment. The standard ICD9 finding of an emotional well-being problem was not related to a higher discontinuation rate. Conclusion: Taking everything into account, pretreatment liver biopsy was not a positive indicator for treatment culmination, and the presence of emotional well-being messes was not a negative indicator for treatment fruition. Keywords: Liver Pretreatment Biopsy, Basic Diagnosis, Mental Health Disorders, Hepatitis C Treatment.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.